Alcidion (ASX:ALC) completes acquisition of the Kyra flow products from Telstra Health
On 29 June 2026, Alcidion completed its acquisition of the business and assets of Kyra Patient Flow Manager, Kyra Queue Manager and Kyra IQ (collectively, the ‘Kyra flow products’) from Telstra Health.
Refer link to initial ASX announcement of the transaction on 18 May 2026.
The Kyra flow products are a proprietary suite of digital solutions that address patient flow and data access challenges across hospital inpatient and outpatient settings in Australia and New Zealand.
The acquisition expands Alcidion’s Australian presence, adding 33 customers and further underpins their position as a leading provider of patient flow solutions across Australia, New Zealand and the UK.
This is the third acquisition Henslow has advised Alcidion on over the past 5 years.
The successful transaction provides a further example of Henslow’s ability to partner with growth companies and provide combined and complementary M&A and equity capital markets (ECM) services.
This transaction further adds to Henslow’s strong track record in the healthcare and technology sectors advising several clients on their M&A search and growth ambitions.
For further information, please contact Scott McInnes (Managing Director) at smcinnes@henslow.com, Justin Lewis (Managing Director) at jlewis@henslow.com and Sebastian Bell (Director) at sbell@henslow.com
